Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-05

AUTHORS

R. Moog, A. Burger, M. Brandl, J. Schüler, R. Schubert, C. Unger, H. Fiebig, U. Massing

ABSTRACT

PURPOSE: The in vivo pharmacokinetics (PK), biodistribution and antitumor activity of a new liposomal formulation of gemcitabine (GemLip) were compared to the conventional (clinical) formulation of gemcitabine (GemConv). METHODS: Gemcitabine was entrapped in a vesicular phospholipid gel (VPG) consisting of densely packed liposomes. Redispersed VPG containing GemLip consisted of 33% liposomally entrapped and 67% free gemcitabine. The in vivo efficacies of GemLip and GemConv were compared using the subcutaneously growing human soft tissue sarcoma SXF 1301 and the orthotopically growing human bladder cancer BXF 1299T. PK and biodistribution were evaluated using radiolabeled drug and lipid in SXF 1301 tumor-bearing nude mice. RESULTS: GemLip was highly active in SXF 1301 at a gemcitabine dose of 6-9 mg/kg (days 1, 8 and 15; dose near the MTD). In the 6-mg/kg groups, complete tumor remissions were observed in seven of eight mice. Equimolar doses of GemConv resulted in only moderate tumor growth inhibition. Even at equitoxic doses (360 mg/kg given on days 1, 8 and 15, or 120 mg/kg on days 1, 5 and 8) GemConv was less active than GemLip. Furthermore, GemLip was active in the orthotopically growing BXF 1299T bladder cancer model at 6 mg/kg and prevented distant organ metastasis. In the PK study, GemLip achieved a 35-fold higher plasma AUC (1680 mg x h/ml) than GemConv (47.6 mg x h/ml). The serum half-lives were 0.15 h for free gemcitabine and 13.3 h for liposomal gemcitabine (6 mg/kg each i.v.). Moreover, gemcitabine levels in tumors were fourfold higher following injection of GemLip than following injection of GemConv. CONCLUSIONS: GemLip is a highly effective gemcitabine delivery system which results in superior gemcitabine pharmacodynamics and PK than GemConv. The enhanced in vivo efficacy might be explained by sustained release and passive tumor targeting. More... »

PAGES

356-366

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-002-0428-4

DOI

http://dx.doi.org/10.1007/s00280-002-0428-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1040250608

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11976829


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Phytogenic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gels", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Half-Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liposomes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Paclitaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phospholipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Taxoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Heterologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urinary Bladder Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vindesine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moog", 
        "givenName": "R.", 
        "id": "sg:person.01067516725.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067516725.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burger", 
        "givenName": "A.", 
        "id": "sg:person.01260567727.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260567727.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Arctic University of Norway", 
          "id": "https://www.grid.ac/institutes/grid.10919.30", 
          "name": [
            "Universitetet i Troms\u00f8, Institutt for Farmasi, 9037 Troms\u00f8, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brandl", 
        "givenName": "M.", 
        "id": "sg:person.01031350715.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031350715.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sch\u00fcler", 
        "givenName": "J.", 
        "id": "sg:person.0714634352.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714634352.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Freiburg", 
          "id": "https://www.grid.ac/institutes/grid.5963.9", 
          "name": [
            "Albert-Ludwigs-University Freiburg, Department Pharmaceutical Technology, Hermann-Herder-Strasse 9, 79104 Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schubert", 
        "givenName": "R.", 
        "id": "sg:person.01151060675.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151060675.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Unger", 
        "givenName": "C.", 
        "id": "sg:person.0704572215.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704572215.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fiebig", 
        "givenName": "H.", 
        "id": "sg:person.016307262115.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016307262115.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Massing", 
        "givenName": "U.", 
        "id": "sg:person.01150377512.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150377512.40"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2002-05", 
    "datePublishedReg": "2002-05-01", 
    "description": "PURPOSE: The in vivo pharmacokinetics (PK), biodistribution and antitumor activity of a new liposomal formulation of gemcitabine (GemLip) were compared to the conventional (clinical) formulation of gemcitabine (GemConv).\nMETHODS: Gemcitabine was entrapped in a vesicular phospholipid gel (VPG) consisting of densely packed liposomes. Redispersed VPG containing GemLip consisted of 33% liposomally entrapped and 67% free gemcitabine. The in vivo efficacies of GemLip and GemConv were compared using the subcutaneously growing human soft tissue sarcoma SXF 1301 and the orthotopically growing human bladder cancer BXF 1299T. PK and biodistribution were evaluated using radiolabeled drug and lipid in SXF 1301 tumor-bearing nude mice.\nRESULTS: GemLip was highly active in SXF 1301 at a gemcitabine dose of 6-9 mg/kg (days 1, 8 and 15; dose near the MTD). In the 6-mg/kg groups, complete tumor remissions were observed in seven of eight mice. Equimolar doses of GemConv resulted in only moderate tumor growth inhibition. Even at equitoxic doses (360 mg/kg given on days 1, 8 and 15, or 120 mg/kg on days 1, 5 and 8) GemConv was less active than GemLip. Furthermore, GemLip was active in the orthotopically growing BXF 1299T bladder cancer model at 6 mg/kg and prevented distant organ metastasis. In the PK study, GemLip achieved a 35-fold higher plasma AUC (1680 mg x h/ml) than GemConv (47.6 mg x h/ml). The serum half-lives were 0.15 h for free gemcitabine and 13.3 h for liposomal gemcitabine (6 mg/kg each i.v.). Moreover, gemcitabine levels in tumors were fourfold higher following injection of GemLip than following injection of GemConv.\nCONCLUSIONS: GemLip is a highly effective gemcitabine delivery system which results in superior gemcitabine pharmacodynamics and PK than GemConv. The enhanced in vivo efficacy might be explained by sustained release and passive tumor targeting.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-002-0428-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "49"
      }
    ], 
    "name": "Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels", 
    "pagination": "356-366", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "bfbd1d59f089668b780da681db8a74e8a83aa8569e3c47d448904e3f4d473f59"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11976829"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-002-0428-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1040250608"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-002-0428-4", 
      "https://app.dimensions.ai/details/publication/pub.1040250608"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000490.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00280-002-0428-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-002-0428-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-002-0428-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-002-0428-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-002-0428-4'


 

This table displays all metadata directly associated to this object as RDF triples.

209 TRIPLES      20 PREDICATES      48 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-002-0428-4 schema:about N047f274e7f0943569fbb05d0b39d36e0
2 N26cbb0fba7f841328f2c12f13faea6d4
3 N3d2a8afbf7ce46ca8cc3d5691c420d08
4 N5fe301ce6b7e433bbb9347ccd2328786
5 N64aab559da024dbabf7ba9344c37d95f
6 N783777ba6f134e9bb9cf221021c3f608
7 N8c3cbbb7cd164740b05d4e617fed5385
8 N9a73211aba07484597fbf5246747a40a
9 N9d9444880532446a84e5bc311638c84a
10 Nbaeddf36449c440490d08ed80f7ffcaa
11 Nbeb8fd9f34974bd699a64e454f3cd65f
12 Nc0c48c46e7ad46cbbb49c52fbd3a33d3
13 Ncab95dde320f4bd7b8627f6378399b65
14 Nce627048e0594698a5b1eb1bb5130404
15 Ncf7866f9b6774cbe86201cf2ec768e7b
16 Ne94a6fd5b9754e99af5af2d011b1f1c0
17 Ned58f0b2b034412ba181197fca735f6e
18 Nf54775d5647642f6b46a448299ff20ae
19 Nf716c01406e5460aaf3f70d544f2f8c4
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author N60980ba419e647ddac35bcd5eb2029f7
23 schema:datePublished 2002-05
24 schema:datePublishedReg 2002-05-01
25 schema:description PURPOSE: The in vivo pharmacokinetics (PK), biodistribution and antitumor activity of a new liposomal formulation of gemcitabine (GemLip) were compared to the conventional (clinical) formulation of gemcitabine (GemConv). METHODS: Gemcitabine was entrapped in a vesicular phospholipid gel (VPG) consisting of densely packed liposomes. Redispersed VPG containing GemLip consisted of 33% liposomally entrapped and 67% free gemcitabine. The in vivo efficacies of GemLip and GemConv were compared using the subcutaneously growing human soft tissue sarcoma SXF 1301 and the orthotopically growing human bladder cancer BXF 1299T. PK and biodistribution were evaluated using radiolabeled drug and lipid in SXF 1301 tumor-bearing nude mice. RESULTS: GemLip was highly active in SXF 1301 at a gemcitabine dose of 6-9 mg/kg (days 1, 8 and 15; dose near the MTD). In the 6-mg/kg groups, complete tumor remissions were observed in seven of eight mice. Equimolar doses of GemConv resulted in only moderate tumor growth inhibition. Even at equitoxic doses (360 mg/kg given on days 1, 8 and 15, or 120 mg/kg on days 1, 5 and 8) GemConv was less active than GemLip. Furthermore, GemLip was active in the orthotopically growing BXF 1299T bladder cancer model at 6 mg/kg and prevented distant organ metastasis. In the PK study, GemLip achieved a 35-fold higher plasma AUC (1680 mg x h/ml) than GemConv (47.6 mg x h/ml). The serum half-lives were 0.15 h for free gemcitabine and 13.3 h for liposomal gemcitabine (6 mg/kg each i.v.). Moreover, gemcitabine levels in tumors were fourfold higher following injection of GemLip than following injection of GemConv. CONCLUSIONS: GemLip is a highly effective gemcitabine delivery system which results in superior gemcitabine pharmacodynamics and PK than GemConv. The enhanced in vivo efficacy might be explained by sustained release and passive tumor targeting.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N8d961bc9acf24d7c9c95d032b408ba39
30 N99c55897505f445c82c499313cc2b638
31 sg:journal.1088364
32 schema:name Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels
33 schema:pagination 356-366
34 schema:productId N017448e627de474ab73263afd86e7489
35 N167015f085814098b0ce51271e210fba
36 N699a615cd2d34238ba4a5f665548e8b0
37 N7a00c957212b4dd18e4db6cb2a431728
38 Naa049733d8cf4b43b0e603e6b6929932
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040250608
40 https://doi.org/10.1007/s00280-002-0428-4
41 schema:sdDatePublished 2019-04-10T22:27
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N9e921e27831f4c278aee3b633711df30
44 schema:url http://link.springer.com/10.1007/s00280-002-0428-4
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N017448e627de474ab73263afd86e7489 schema:name dimensions_id
49 schema:value pub.1040250608
50 rdf:type schema:PropertyValue
51 N047f274e7f0943569fbb05d0b39d36e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Tissue Distribution
53 rdf:type schema:DefinedTerm
54 N167015f085814098b0ce51271e210fba schema:name nlm_unique_id
55 schema:value 7806519
56 rdf:type schema:PropertyValue
57 N1f82f2e4f898478c8d1860a6727b8706 schema:name Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany
58 rdf:type schema:Organization
59 N26cbb0fba7f841328f2c12f13faea6d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Humans
61 rdf:type schema:DefinedTerm
62 N2a9bbd234b18427f87e9d67ac07e3756 rdf:first sg:person.0714634352.53
63 rdf:rest N5f356b249b49466fbf5d886f9e1ed0aa
64 N3d2a8afbf7ce46ca8cc3d5691c420d08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Paclitaxel
66 rdf:type schema:DefinedTerm
67 N58d38b323c984c22bbbab2cb5ff75a14 rdf:first sg:person.01031350715.95
68 rdf:rest N2a9bbd234b18427f87e9d67ac07e3756
69 N5f356b249b49466fbf5d886f9e1ed0aa rdf:first sg:person.01151060675.54
70 rdf:rest Ne3591522cb2545f087e77724c8816fa4
71 N5fe301ce6b7e433bbb9347ccd2328786 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Antineoplastic Agents, Phytogenic
73 rdf:type schema:DefinedTerm
74 N60980ba419e647ddac35bcd5eb2029f7 rdf:first sg:person.01067516725.39
75 rdf:rest Na3cdfb6e049c42ee892866e06ff4cafc
76 N64aab559da024dbabf7ba9344c37d95f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Gels
78 rdf:type schema:DefinedTerm
79 N68383920594d4622babe63842371ad7e schema:name Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany
80 rdf:type schema:Organization
81 N699a615cd2d34238ba4a5f665548e8b0 schema:name readcube_id
82 schema:value bfbd1d59f089668b780da681db8a74e8a83aa8569e3c47d448904e3f4d473f59
83 rdf:type schema:PropertyValue
84 N6eb662e970d74030844bbc447925b101 schema:name Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany
85 rdf:type schema:Organization
86 N729c298796a34c22be9b9fa58b36a74e schema:name Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany
87 rdf:type schema:Organization
88 N783777ba6f134e9bb9cf221021c3f608 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Antimetabolites, Antineoplastic
90 rdf:type schema:DefinedTerm
91 N7a00c957212b4dd18e4db6cb2a431728 schema:name doi
92 schema:value 10.1007/s00280-002-0428-4
93 rdf:type schema:PropertyValue
94 N8c3cbbb7cd164740b05d4e617fed5385 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Urinary Bladder Neoplasms
96 rdf:type schema:DefinedTerm
97 N8d961bc9acf24d7c9c95d032b408ba39 schema:issueNumber 5
98 rdf:type schema:PublicationIssue
99 N99c55897505f445c82c499313cc2b638 schema:volumeNumber 49
100 rdf:type schema:PublicationVolume
101 N9a73211aba07484597fbf5246747a40a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Vindesine
103 rdf:type schema:DefinedTerm
104 N9d9444880532446a84e5bc311638c84a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Sarcoma
106 rdf:type schema:DefinedTerm
107 N9e921e27831f4c278aee3b633711df30 schema:name Springer Nature - SN SciGraph project
108 rdf:type schema:Organization
109 Na3cdfb6e049c42ee892866e06ff4cafc rdf:first sg:person.01260567727.86
110 rdf:rest N58d38b323c984c22bbbab2cb5ff75a14
111 Naa049733d8cf4b43b0e603e6b6929932 schema:name pubmed_id
112 schema:value 11976829
113 rdf:type schema:PropertyValue
114 Nafdd3d28c1774770ad7ccc7352ee1ce8 rdf:first sg:person.016307262115.28
115 rdf:rest Neb07eeb2b5bf4b039d59bc743e7cf12f
116 Nbaeddf36449c440490d08ed80f7ffcaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Transplantation, Heterologous
118 rdf:type schema:DefinedTerm
119 Nbeb8fd9f34974bd699a64e454f3cd65f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Animals
121 rdf:type schema:DefinedTerm
122 Nc0c48c46e7ad46cbbb49c52fbd3a33d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Deoxycytidine
124 rdf:type schema:DefinedTerm
125 Ncab95dde320f4bd7b8627f6378399b65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Liposomes
127 rdf:type schema:DefinedTerm
128 Nce627048e0594698a5b1eb1bb5130404 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Mice
130 rdf:type schema:DefinedTerm
131 Ncf7866f9b6774cbe86201cf2ec768e7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Half-Life
133 rdf:type schema:DefinedTerm
134 Nd1a65667a0c349588508cea3c30dd409 schema:name Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany
135 rdf:type schema:Organization
136 Ne3591522cb2545f087e77724c8816fa4 rdf:first sg:person.0704572215.43
137 rdf:rest Nafdd3d28c1774770ad7ccc7352ee1ce8
138 Ne94a6fd5b9754e99af5af2d011b1f1c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Mice, Nude
140 rdf:type schema:DefinedTerm
141 Neb07eeb2b5bf4b039d59bc743e7cf12f rdf:first sg:person.01150377512.40
142 rdf:rest rdf:nil
143 Ned58f0b2b034412ba181197fca735f6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Phospholipids
145 rdf:type schema:DefinedTerm
146 Nf54775d5647642f6b46a448299ff20ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Taxoids
148 rdf:type schema:DefinedTerm
149 Nf716c01406e5460aaf3f70d544f2f8c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Neoplasm Transplantation
151 rdf:type schema:DefinedTerm
152 Nf9d48016ef2d49b692e2bee81cc6d71e schema:name Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106 Freiburg, Germany
153 rdf:type schema:Organization
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
158 schema:name Oncology and Carcinogenesis
159 rdf:type schema:DefinedTerm
160 sg:journal.1088364 schema:issn 0344-5704
161 1432-0843
162 schema:name Cancer Chemotherapy and Pharmacology
163 rdf:type schema:Periodical
164 sg:person.01031350715.95 schema:affiliation https://www.grid.ac/institutes/grid.10919.30
165 schema:familyName Brandl
166 schema:givenName M.
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031350715.95
168 rdf:type schema:Person
169 sg:person.01067516725.39 schema:affiliation N729c298796a34c22be9b9fa58b36a74e
170 schema:familyName Moog
171 schema:givenName R.
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067516725.39
173 rdf:type schema:Person
174 sg:person.01150377512.40 schema:affiliation N6eb662e970d74030844bbc447925b101
175 schema:familyName Massing
176 schema:givenName U.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150377512.40
178 rdf:type schema:Person
179 sg:person.01151060675.54 schema:affiliation https://www.grid.ac/institutes/grid.5963.9
180 schema:familyName Schubert
181 schema:givenName R.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151060675.54
183 rdf:type schema:Person
184 sg:person.01260567727.86 schema:affiliation N68383920594d4622babe63842371ad7e
185 schema:familyName Burger
186 schema:givenName A.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260567727.86
188 rdf:type schema:Person
189 sg:person.016307262115.28 schema:affiliation N1f82f2e4f898478c8d1860a6727b8706
190 schema:familyName Fiebig
191 schema:givenName H.
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016307262115.28
193 rdf:type schema:Person
194 sg:person.0704572215.43 schema:affiliation Nd1a65667a0c349588508cea3c30dd409
195 schema:familyName Unger
196 schema:givenName C.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704572215.43
198 rdf:type schema:Person
199 sg:person.0714634352.53 schema:affiliation Nf9d48016ef2d49b692e2bee81cc6d71e
200 schema:familyName Schüler
201 schema:givenName J.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714634352.53
203 rdf:type schema:Person
204 https://www.grid.ac/institutes/grid.10919.30 schema:alternateName The Arctic University of Norway
205 schema:name Universitetet i Tromsø, Institutt for Farmasi, 9037 Tromsø, Norway
206 rdf:type schema:Organization
207 https://www.grid.ac/institutes/grid.5963.9 schema:alternateName University of Freiburg
208 schema:name Albert-Ludwigs-University Freiburg, Department Pharmaceutical Technology, Hermann-Herder-Strasse 9, 79104 Freiburg, Germany
209 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...